LINC01411

Across TCGA pan-cancer cohorts, LINC01411 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of LINC01411’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where LINC01411 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01411 is over-expressed in tumor.

COAD, UCEC, and BLCA are the cancer types where LINC01411 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01411 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.867	<.001	6	view →
UCEC	All	All	+0.764	.014	6	view →
BLCA	All	IV	+0.248	.004	4	view →
HNSC	All	All	+0.047	.026	4	view →
KIRP	All	III,IV	+0.470	.015	3	view →
KIRC	All	All	+0.297	.013	3	view →
READ	All	All	+1.950	.033	2	view →
PRAD	All	All	+0.465	.012	2	view →
BRCA	All	All	+0.370	.006	2	view →
CHOL	All	All	+0.322	.022	2	view →
LUSC	All	All	+0.060	.001	2	view →
LUAD	Male	II,III,IV	+0.033	.008	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

LINC01411–COAD

Open the COAD breakdown →